Bragg Peak Systems, Inc. is a leading medical device manufacturer focused on advancing particle therapy systems for cancer treatment. The company offers a range of products including the Akuritron Omni carbon ion system, Akuritron Pro upgradable proton system, Bragg Peak Solo modularized proton system, and the Akurisition 6D patient positioning system. Additionally, they provide particle therapy planning and management systems, as well as accelerator engines. Their mission is to bring an FDA 510k approved carbon ion system to market, emphasizing cost-effectiveness and innovation.

Bragg Peak Systems has made significant strides in the medical device industry by offering advanced and financially accessible particle therapy solutions. Their systems are designed to optimize treatment accuracy and adaptability, providing real-time adjustable and clean treatment options. The company's approach has positioned them as a key player in the market, with their FDA-approved carbon ion system being a notable achievement. Their innovative financial model and commitment to avoiding industry pitfalls have garnered attention and support from various stakeholders in the healthcare sector.